Chemical Synthesis of the Anti-COVID-19 Drug Remdesivir

被引：3
|
作者：
Wang, Mo [1 ,2 ]
Zhang, Lu [2 ]
Huo, Xiaohong [1 ]
Zhang, Zhenfeng [2 ]
Zhang, Wanbin [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, Frontiers Sci Ctr Transformat Mol, Shanghai Key Lab Mol Engn Chiral Drugs, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China
来源：
CURRENT PROTOCOLS | 2021年 / 1卷 / 12期
基金：
国家重点研发计划; 中国国家自然科学基金;
关键词：
anti-COVID-19; drug; asymmetric phosphorylation; chiral bicyclic imidazole; organocatalysis; ENANTIOSELECTIVE C-ACYLATION; KINETIC RESOLUTION; GS-5734; DESIGN; EBOLA;
D O I：
10.1002/cpz1.303
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Remdesivir has become an important compound for the treatment of COVID-19. Here, we describe the catalytic asymmetric synthesis of this anti-COVID-19 drug. First, the P-racemic phosphoryl chloride is synthesized in a facile procedure. Then, it is possible to obtain the protected remdesivir via the organocatalytic asymmetric phosphorylation of protected nucleoside GS441524 with P-racemic phosphoryl chloride catalyzed by chiral bicyclic imidazole. Finally, remdesivir is easily prepared by deprotection. (c) 2021 Wiley Periodicals LLC.
引用
收藏
页数：10
相关论文
共 50 条
  • [21] Hypertension after anti-COVID-19 vaccination
    Angeli, Fabio
    Reboldi, Gianpaolo
    Trapasso, Monica
    Verdecchia, Paolo
    GIORNALE ITALIANO DI CARDIOLOGIA, 2022, 23 (01) : 10 - 14
  • [22] Deploying Biomolecules as Anti-COVID-19 Agents
    Patel, Sanjay K. S.
    Lee, Jung-Kul
    Kalia, Vipin C.
    INDIAN JOURNAL OF MICROBIOLOGY, 2020, 60 (03) : 263 - 268
  • [23] Suspicion of allergy to anti-COVID-19 vaccines
    Kleebayoon, A.
    Wiwanitkit, V.
    REVUE FRANCAISE D ALLERGOLOGIE, 2023, 63 (04):
  • [24] Subcutaneous anti-COVID-19 hyperimmune immunoglobulin
    Alemany, Andrea
    Millat-Martinez, Pere
    Corbacho-Monne, Marc
    Suner, Clara
    Galvan-Casas, Cristina
    Carrera, Caty
    Ouchi, Dan
    Prat, Nuria
    Ara, Jordi
    Nadal, Nuria
    Riel, Ricard
    Funollet, Blanca
    Ojeda-Ciurana, Carmen
    Balague, Lluis Esteve
    Salvador-Gonzalez, Betlem
    Arcarons, Anna Forcada
    Vidal-Alaball, Josep
    Del Cura-Gonzalez, Maria Isabel
    Barrientos, Ricardo Rodriguez
    Ramos-Blanes, Rafel
    Bou, Alberto Alum
    Mondou, Elsa
    Torres, Mireia
    Campins, Neus
    Sanz, Ana
    Tang, Yonggiang
    Rodriguez-Arias, Miquel Angel
    Bassat, Quique
    Clotet, Bonaventura
    Mitja, Oriol
    ECLINICALMEDICINE, 2023, 57
  • [25] Deploying Biomolecules as Anti-COVID-19 Agents
    Sanjay K. S. Patel
    Jung-Kul Lee
    Vipin C. Kalia
    Indian Journal of Microbiology, 2020, 60 : 263 - 268
  • [26] Seborrheic dermatitis and anti-COVID-19 masks
    Veraldi, Stefano
    Angileri, Luisa
    Barbareschi, Mauro
    JOURNAL OF COSMETIC DERMATOLOGY, 2020, 19 (10) : 2464 - 2465
  • [27] Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters
    Telbisz, Agnes
    Ambrus, Csilla
    Mozner, Orsolya
    Szabo, Edit
    Varady, Gyorgy
    Bakos, Eva
    Sarkadi, Balazs
    Ozvegy-Laczka, Csilla
    PHARMACEUTICS, 2021, 13 (01) : 1 - 18
  • [28] Anti-COVID-19 drugs, COVID-19 and anesthetics - The challenge for anesthesiologists
    Garg, Rakesh
    Yadav, Pratishtha
    JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY, 2022, 38 : 140 - 141
  • [29] Research and development of Chinese anti-COVID-19 drugs
    Ji, Xiwei
    Meng, Xiangrui
    Zhu, Xiao
    He, Qingfeng
    Cui, Yimin
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (12) : 4271 - 4286
  • [30] Protective features of anti-COVID-19 immune response
    Diem, Gabriel
    Jaeger, Michael
    Dichtl, Stefanie
    Bauer, Angelika
    Lass-Floerl, Cornelia
    Reindl, Markus
    Wilflingseder, Doris
    Posch, Wilfried
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 12 - 12
12345